Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvaro®ODT in Dyslipidemia
NCT06153433Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Nov 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Suvaro in dyslipidemia, sponsored by Yonsei University. Status: unknown.
02
Drugs
Suvaro
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT06153433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06153433.